» Articles » PMID: 9818613

Risk Factors for Noncompliance with Glaucoma Follow-up Visits in a Residents' Eye Clinic

Overview
Journal Ophthalmology
Publisher Elsevier
Specialty Ophthalmology
Date 1998 Nov 18
PMID 9818613
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aimed to identify factors associated with compliance with glaucoma follow-up visits.

Design: Computer records of a university residents' eye clinic were reviewed to identify a random sample of all persons who had an examination with International Classification of Disease (ICD) 9 coding (ICD9) for glaucoma suspect or glaucoma during a 2-year period (1991-1993) to undergo telephone interview.

Participants: Those who were seen at least every 6 months regardless of earlier return instructions were defined as compliant with follow-up (controls, n = 362). Those who had any lapse between visits of longer than 6 months were defined as noncompliant (cases, n = 362).

Results: Interviews were completed for 196 cases and 242 controls. Noncompliant persons were significantly more likely to be suspects for glaucoma rather than to have definite glaucoma and to be dissatisfied with waiting time in the clinic (29.1% vs. 17.8%, P < 0.005) and to state that they did not take their glaucoma medications as prescribed (25.4% vs. 13.4%, P < 0.004). They also were less likely to have been prescribed eyedrop medication. A high percentage of both patients and controls knew that glaucoma can lead to blindness (85.2% and 88.4%, respectively). The most common reasons patients gave for not keeping follow-up visits were the perception that their eye problem was "not serious enough," the cost of examinations, and that the doctor did not tell them to come back.

Conclusion: Compliance with follow-up visits for glaucoma is associated with markers for early disease. Attempts to improve compliance might focus on improved communication of the seriousness of the disease and improvements in clinic waiting time.

Citing Articles

12-month Safety and Efficacy Outcomes of a Standalone Trabecular Bypass Device.

Huynh B, Clement C, Nguyen V, Ohagan S, Howes F, Macken P J Curr Glaucoma Pract. 2024; 18(3):103-109.

PMID: 39575127 PMC: 11576339. DOI: 10.5005/jp-journals-10078-1447.


Factors Associated with Nonreturn after Loss to Follow-Up from Glaucoma Care: An IRIS® Registry Retrospective Analysis.

Wasser L, Cassidy J, Lin H, Williams A Ophthalmol Glaucoma. 2024; 7(6):572-579.

PMID: 39038740 PMC: 11585456. DOI: 10.1016/j.ogla.2024.07.007.


Decomposition of socioeconomic inequalities in glaucoma knowledge in Taiwan.

Hou C, Pu C Epidemiol Health. 2023; 46:e2024004.

PMID: 38147820 PMC: 10928472. DOI: 10.4178/epih.e2024004.


Barriers and Facilitators to Ophthalmology Visit Adherence in an Urban Hospital Setting.

Scanzera A, Sherrod R, Potharazu A, Nguyen D, Beversluis C, Karnik N Transl Vis Sci Technol. 2023; 12(10):11.

PMID: 37831446 PMC: 10587857. DOI: 10.1167/tvst.12.10.11.


Factors Affecting Glaucoma Medication Adherence and Interventions to Improve Adherence: A Narrative Review.

Moore S, Richter G, Modjtahedi B Ophthalmol Ther. 2023; 12(6):2863-2880.

PMID: 37698824 PMC: 10640536. DOI: 10.1007/s40123-023-00797-8.